Recent studies show indeed that MS-associated genetic variants alter the expression of co-stimulatory molecule, including CD40 in B cells, as well as the level of steering cytokines such as interleukin-10, which is considered to have an immunoregulatory function downstream of CD40 (43). This evidence concerns the gene CD40 and myeloid sarcoma.